NCT05388058 2026-01-16
Topical Cannabidiol for the Treatment of Chemotherapy-Induced Peripheral Neuropathy
Mayo Clinic
Phase 2 Completed
Mayo Clinic
British Columbia Cancer Agency
University of Michigan Rogel Cancer Center
University of Copenhagen
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.
Jazz Pharmaceuticals
Hugo W. Moser Research Institute at Kennedy Krieger, Inc.